Simon C. Johnson

6.1k total citations · 1 hit paper
42 papers, 3.5k citations indexed

About

Simon C. Johnson is a scholar working on Molecular Biology, Clinical Biochemistry and Aging. According to data from OpenAlex, Simon C. Johnson has authored 42 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 10 papers in Clinical Biochemistry and 10 papers in Aging. Recurrent topics in Simon C. Johnson's work include Mitochondrial Function and Pathology (22 papers), Metabolism and Genetic Disorders (10 papers) and Genetics, Aging, and Longevity in Model Organisms (10 papers). Simon C. Johnson is often cited by papers focused on Mitochondrial Function and Pathology (22 papers), Metabolism and Genetic Disorders (10 papers) and Genetics, Aging, and Longevity in Model Organisms (10 papers). Simon C. Johnson collaborates with scholars based in United States, United Kingdom and France. Simon C. Johnson's co-authors include Peter S. Rabinovitch, Matt Kaeberlein, Dao‐Fu Dai, Hazel H. Szeto, Tony Chen, Philip G. Morgan, Margaret M. Sedensky, Maya Sangesland, Michael T. Chin and Madeline Nieves‐Cintrón and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

Simon C. Johnson

41 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mTOR is a key modulator of ageing and age-related disease

2013 1.3k citations Simon C. Johnson, Peter S. Rabinovitch et al. profile →

Peers

Countries citing papers authored by Simon C. Johnson

Since Specialization

Citations

This map shows the geographic impact of Simon C. Johnson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Simon C. Johnson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Simon C. Johnson more than expected).

Fields of papers citing papers by Simon C. Johnson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Simon C. Johnson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Simon C. Johnson. The network helps show where Simon C. Johnson may publish in the future.

Co-authorship network of co-authors of Simon C. Johnson

This figure shows the co-authorship network connecting the top 25 collaborators of Simon C. Johnson. A scholar is included among the top collaborators of Simon C. Johnson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Simon C. Johnson. Simon C. Johnson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluating the efficacy of vatiquinone in preclinical models of Leigh syndrome and GPX4 deficiency 2025 ·Orphanet Journal of Rare Diseases ·Ernst‐Bernhard Kayser, Michael Mulholland, (unknown), Yihan Chen, (unknown), (unknown), (unknown), (unknown), (unknown), Allison R. Hanaford, Simon C. Johnson	1
2	Impact of dietary ketosis on volatile anesthesia toxicity in a model of Leigh syndrome 2024 ·Pediatric Anesthesia ·(unknown), Miranda Howe, Michael Mulholland, (unknown), (unknown), Yihan Chen, (unknown), (unknown), Allison R. Hanaford, (unknown), Philip G. Morgan, Margaret M. Sedensky, Simon C. Johnson	2
3	Interferon‐gamma contributes to disease progression in the Ndufs4 (−/−) model of Leigh syndrome 2024 ·Neuropathology and Applied Neurobiology ·Allison R. Hanaford, (unknown), (unknown), (unknown), (unknown), Yihan Chen, Michael Mulholland, Ernst‐Bernhard Kayser, (unknown), (unknown), Margaret M. Sedensky, Philip G. Morgan, Vandana Kalia, Surojit Sarkar, Simon C. Johnson	4
4	Peripheral macrophages drive CNS disease in the Ndufs4(−/−) model of Leigh syndrome 2023 ·Brain Pathology ·Allison R. Hanaford, (unknown), (unknown), (unknown), (unknown), Michael Mulholland, (unknown), (unknown), Margaret M. Sedensky, Philip G. Morgan, Nathan A. Baertsch, Vandana Kalia, Surojit Sarkar, Simon C. Johnson	8
5	Volatile anaesthetic toxicity in the genetic mitochondrial disease Leigh syndrome 2023 ·British Journal of Anaesthesia ·(unknown), Michael Mulholland, John Snell, Miranda Howe, (unknown), Allison R. Hanaford, Philip G. Morgan, Margaret M. Sedensky, Simon C. Johnson	6
6	The immune system as a driver of mitochondrial disease pathogenesis: a review of evidence 2022 ·Orphanet Journal of Rare Diseases ·Allison R. Hanaford, Simon C. Johnson	30
7	Leukocytes mediate disease pathogenesis in the Ndufs4(KO) mouse model of Leigh syndrome 2022 ·JCI Insight ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Philip G. Morgan, Margaret M. Sedensky, Nathan A. Baertsch, Simon C. Johnson	33
8	Tetraethylammonium chloride reduces anaesthetic-induced neurotoxicity in Caenorhabditis elegans and mice 2021 ·British Journal of Anaesthesia ·(unknown), Ernst‐Bernhard Kayser, Simon C. Johnson, Li Li, (unknown), (unknown), Margaret M. Sedensky, Philip G. Morgan	3
9	Development of therapies for rare genetic disorders of GPX4: roadmap and opportunities 2021 ·Orphanet Journal of Rare Diseases ·Dorian M. Cheff, Alysson R. Muotri, Brent R. Stockwell, Edward E. Schmidt, Qitao Ran, Reena V. Kartha, Simon C. Johnson, Plavi Mittal, Elias S.J. Arnér, Kristen Wigby, Matthew D. Hall, Sanath Kumar Ramesh	14
10	Regional metabolic signatures in the Ndufs4(KO) mouse brain implicate defective glutamate/α-ketoglutarate metabolism in mitochondrial disease 2020 ·Molecular Genetics and Metabolism ·Simon C. Johnson, Ernst‐Bernhard Kayser, (unknown), (unknown), Alessandro Bitto, (unknown), (unknown), (unknown), Daniel Raftery, Matt Kaeberlein, Margaret M. Sedensky, Philip G. Morgan	25
11	mTOR inhibitors may benefit kidney transplant recipients with mitochondrial diseases 2018 ·Kidney International ·Simon C. Johnson, Frank Martinez, Alessandro Bitto, Brenda González, (unknown), Camille Cohen, (unknown), José Timsit, Bertrand Knebelmann, Fabiola Terzi, (unknown), Yizhou Zhu, Philip G. Morgan, Margaret M. Sedensky, Matt Kaeberlein, Christophe Legendre, Yousin Suh, Guillaume Canaud	40
12	Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease 2018 ·Sub-cellular biochemistry ·Simon C. Johnson	61
13	Network analysis of mitonuclear GWAS reveals functional networks and tissue expression profiles of disease-associated genes 2016 ·Human Genetics ·Simon C. Johnson, Brenda González, Quanwei Zhang, Brandon Milholland, Zhengdong Zhang, Yousin Suh	15
14	Dose-dependent effects of mTOR inhibition on weight and mitochondrial disease in mice 2015 ·Frontiers in Genetics ·Simon C. Johnson, (unknown), Alessandro Bitto, Anthony S. Castanza, (unknown), Brenda González, (unknown), Jessica Hui, (unknown), (unknown), (unknown), (unknown), Maya Sangesland, (unknown), (unknown), (unknown), Peter S. Rabinovitch, Yousin Suh, Matt Kaeberlein	71
15	New Generation of Artificial MicroRNA and Synthetic Trans-Acting Small Interfering RNA Vectors for Efficient Gene Silencing in Arabidopsis 2014 ·PLANT PHYSIOLOGY ·Alberto Carbonell, Atsushi Takeda, Noah Fahlgren, Simon C. Johnson, Josh T. Cuperus, James C. Carrington	107
16	Modulating mTOR in Aging and Health 2014 ·PubMed ·Simon C. Johnson, Maya Sangesland, Matt Kaeberlein, Peter S. Rabinovitch	75
17	mTOR Inhibition Alleviates Mitochondrial Disease in a Mouse Model of Leigh Syndrome 2013 ·Science ·Simon C. Johnson, (unknown), Ernst‐Bernhard Kayser, Albert Quintana, Maya Sangesland, Anthony S. Castanza, (unknown), Jessica Hui, Valerie Wall, (unknown), Kelly H. Oh, Brian M. Wasko, Fresnida J. Ramos, Richard D. Palmiter, Peter S. Rabinovitch, Philip G. Morgan, Margaret M. Sedensky, Matt Kaeberlein	401
18	DNA damage accumulation and TRF2 degradation in atypical Werner syndrome fibroblasts with LMNA mutations 2013 ·Frontiers in Genetics ·Bidisha Saha, Galynn Zitnik, Simon C. Johnson, Quyen T. Nguyen, Rosa Ana Risques, George M. Martin, Junko Oshima	29
19	Mitochondrial Oxidative Stress Mediates Angiotensin II–Induced Cardiac Hypertrophy and Gαq Overexpression–Induced Heart Failure 2011 ·Circulation Research ·Dao‐Fu Dai, Simon C. Johnson, Jason J. Villarin, Michael T. Chin, Madeline Nieves‐Cintrón, Chien‐Jen Chen, David J. Marcinek, Gerald W. Dorn, Y. James Kang, Tomas A. Prolla, Luis F. Santana, Peter S. Rabinovitch	419
20	Do Mitochondria Regulate Cellular Iron Homeostasis Through Citric Acid and Heme Production? Implications for Cancer and Other Diseases 2001 ·SSRN Electronic Journal ·Simon C. Johnson	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact